Clinical Trials Browser

Phase 2 × INDUSTRY × Burns × Clear all

NCT00236041 2014-05-09

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Phase 2 Completed

Classical hematology

Agnosia, Anemia, Sickle Cell, Burns, Neoplasms, Breakthrough Pain

NCT00236093 2014-05-09

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

Phase 2 Completed

Classical hematology

Anemia, Sickle Cell, Burns, Neoplasms, Pain